We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, Plavix-Makers Will Study the Drug’s Efficacy
FDA, Plavix-Makers Will Study the Drug’s Efficacy
January 30, 2009
Bristol-Myers Squibb (BMS) and Sanofi-Aventis will conduct genetic and drug-interaction studies to determine why their blockbuster cardiovascular drug Plavix works better in some patients than in others, the FDA says in a MedWatch report.